Clinical Researcher CBD

As an employer, we genuinely care about our employees' wellbeing and this is reflected in the range of benefits that we offer including:

• An excellent contributory pension scheme

• 38 days annual leave

• A comprehensive range of childcare services

• Family leave schemes

• Cycle loan scheme

• Discounted bus travel and Season Ticket travel loans

• Membership to a variety of social and sports clubs

The University of Oxford is a stimulating work environment, which enjoys an international reputation as a world-class centre of excellence. Our research plays a key role in tackling many global challenges, from reducing our carbon emissions to developing vaccines during a pandemic.

This is an exciting opportunity for a clinical researcher to join a group with an international reputation for research on the mechanisms underlying psychosis and the development of novel treatments as part of STEP, an international multi-centre programme funded by the Wellcome Trust.

You will contribute to the assessment of participants in the early stages of psychosis and healthy controls. You will contribute to the evaluation of CBD as a novel treatment in psychosis in a clinical trial. You will have the opportunity to join ongoing research projects as well as develop your own academic and clinical interests.

The post is funded for 3 years and is based in the Department of Psychiatry at the Warneford Hospital. The post is full time; however, consideration would be given to candidates wishing to work part-time on a pro rata basis.

You will have a medical degree (MBBS MD or equivalent) and have completed your Foundation training or equivalent. You will have a demonstrable strong interest in psychiatric research. You will have excellent communication skills including the ability to form rapport with difficult to engage individuals. Membership of the Royal College of Psychiatrists (MRCPsych) or equivalent would be desirable.